Advertisement
When a safe and effective vaccine against COVID-19 becomes available

Vaccine Campaign Would Take Six to Nine Months to Curb COVID-19

0
First to be vaccinated would be those with health conditions that make them vulnerable to severe illness, death
Of those aged younger than 21 years with deaths associated with severe acute respiratory syndrome coronavirus 2

Characteristics ID’d for Under 21s With SARS-CoV-2-Linked Deaths

0
Teens and young adults, those with underlying medical conditions overrepresented among decedents
A single infusion of an experimental drug dramatically lowers levels of coronavirus in the bodies of newly infected patients and cuts their chances of hospitalization

New Drug Shows Promise in Preventing Severe COVID-19

0
Drug is monoclonal antibody, a man-made copy of antibody produced by a recovered COVID-19 patient
In a sign that Americans are becoming more wary about the safety of a COVID-19 vaccine

Poll: Most Americans Do Not Trust Trump’s COVID-19 Vaccine Comments

0
More than half of adults say they do not trust the president's vaccine comments
Half of practices report having an office dismissal policy for families refusing vaccines

Office Dismissal Policy for Families Refusing Vaccines Common

0
Office policies for dismissal of families more common than physician's dismissal behavior
Factor V activity is significantly increased in patients with severe COVID-19

Factor V Activity Significantly Increased in Severe COVID-19

0
Rates of DVT/PE significantly higher for patients with COVID-19 and elevated factor V activity
Two of three planned adaptive phase 3 clinical trials evaluating the safety and effectiveness of varying types of blood thinners to treat adults diagnosed with COVID-19 have launched

NIH Launches Clinical Trials of Antithrombotics for COVID-19

0
Adaptive design allows evaluation of various doses, types of blood thinners in outpatients, inpatients
From 2011 to 2017

HPV Vaccination Rates Increasing Among 15-Year-Olds

0
Proportion of one- or two-dose HPV vaccination increased from 2011 to 2017; still falling short of goals
The overall prevalence of severe acute respiratory syndrome coronavirus 2 antibodies is 24.4 percent in a cohort of asymptomatic health care workers

24.4 Percent of U.K. Health Care Workers Positive for SARS-CoV-2

0
Seroprevalence varies for health care workers in different departments; rate lower for ICU staff
Vaccine confidence has increased in parts of Europe in recent years

Vaccine Confidence Recently Increased in Some of Europe

0
Confidence in importance, safety, effectiveness of vaccines down in Afghanistan, other countries